' Exciting ' Results for Cancer Vaccine Plus Pembro in Melanoma ' Exciting ' Results for Cancer Vaccine Plus Pembro in Melanoma

Combining Moderna ' s patient-specific mRNA-based cancer vaccine with pembrolizumab may prolong recurrence-free survival in patients with high-risk melanoma vs pembrolizumab alone, new data show.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news